In this week’s podcast, Neurology Today ’s editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer’s therapies, and criteria program directors apply in selecting neurology residents.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident’s 3D printing of brain model.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses what’s known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year’s residency match.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson’s, a newly matched neurology resident, and the winner of the Potamkin Award.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses how Parkinson’s experts choose among the many new and older therapies; decline of antiseizure drug levels in pregnancy, and benefits of endovascular therapy for large core stroke.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses a call to action to address unmet needs of women with Parkinson’s; a promising advance for people with severe spinal cord injuries, and a novel gene therapy for limb girdle muscular dystrophy.
In this week’s podcast, Neurology Today ’s editor-in-chief discusses gender bias in Medicare criteria for sleep apnea; delayed cerebral ischemia with cannabis use; and income disparities between male and female neurologists, and more!
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 3, 2022 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 20, 2022 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 6, 2022 issue
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 16, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 2, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.
